Literature DB >> 1612296

Targeted accumulation of polyethylene glycol-coated immunoliposomes in infarcted rabbit myocardium.

V P Torchilin1, A L Klibanov, L Huang, S O'Donnell, N D Nossiff, B A Khaw.   

Abstract

The less than optimal accumulation of immunoliposome-associated reagents at target sites has often been attributed to the rapid in vivo clearance of immunoliposomes from the blood. In an attempt to overcome the drawback of rapid clearance and use the targeting potential of immunoliposomes, we have prepared long-circulating, 111In-labeled immunoliposomes. Targeting properties and enhanced circulation times were demonstrated in a rabbit model of acute experimental myocardial infarct. The specificity of liposomes for newly exposed intracellular cardiac myosin at the necrotic sites was achieved by incorporating monoclonal antimyosin antibody. Extended circulation times were achieved by cocoating the antimyosin-liposomes with polyethylene glycol (PEG). The half-life of the immunoliposomes was 40 min, which increased to 200 min with 4% mol PEG and to approximately 1000 min with 10% mol PEG. The degree of binding of modified immunoliposomes at the target sites was also dependent on the concentration of PEG incorporated at the liposome surface. This study demonstrates the accumulation of long-circulating targeted liposomes at the area of acute rabbit experimental myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1612296     DOI: 10.1096/fasebj.6.9.1612296

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  26 in total

1.  Nutrient uptake by protocells: a liposome model system.

Authors:  P A Monnard; D W Deamer
Journal:  Orig Life Evol Biosph       Date:  2001 Feb-Apr       Impact factor: 1.950

Review 2.  Liposomes in diagnosis and treatment of cardiovascular disorders.

Authors:  Tatyana S Levchenko; William C Hartner; Vladimir P Torchilin
Journal:  Methodist Debakey Cardiovasc J       Date:  2012-01

Review 3.  Perspectives and opportunities for nanomedicine in the management of atherosclerosis.

Authors:  Mark E Lobatto; Valentin Fuster; Zahi A Fayad; Willem J M Mulder
Journal:  Nat Rev Drug Discov       Date:  2011-10-21       Impact factor: 84.694

4.  Liposomes as nanocarriers for anti-HIV therapy.

Authors:  Shruti Chopra; Natarajan Venkatesan; Guru V Betageri
Journal:  Drug Deliv Transl Res       Date:  2013-10       Impact factor: 4.617

Review 5.  Diamagnetic chemical exchange saturation transfer (diaCEST) liposomes: physicochemical properties and imaging applications.

Authors:  Kannie W Y Chan; Jeff W M Bulte; Michael T McMahon
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-10-08

6.  Structure and phase behavior of lipid suspensions containing phospholipids with covalently attached poly(ethylene glycol).

Authors:  A K Kenworthy; S A Simon; T J McIntosh
Journal:  Biophys J       Date:  1995-05       Impact factor: 4.033

7.  pH (low) insertion peptide (pHLIP) targets ischemic myocardium.

Authors:  Eugene A Sosunov; Evgeny P Anyukhovsky; Alexander A Sosunov; Anna Moshnikova; Dayanjali Wijesinghe; Donald M Engelman; Yana K Reshetnyak; Oleg A Andreev
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

8.  Surface functionalization of doxorubicin-loaded liposomes with octa-arginine for enhanced anticancer activity.

Authors:  Swati Biswas; Namita S Dodwadkar; Pranali P Deshpande; Shruti Parab; Vladimir P Torchilin
Journal:  Eur J Pharm Biopharm       Date:  2013-01-17       Impact factor: 5.571

Review 9.  Immunoconjugates and long circulating systems: origins, current state of the art and future directions.

Authors:  Alexander Koshkaryev; Rupa Sawant; Madhura Deshpande; Vladimir Torchilin
Journal:  Adv Drug Deliv Rev       Date:  2012-09-03       Impact factor: 15.470

10.  A coarse-grained model for polyethylene oxide and polyethylene glycol: conformation and hydrodynamics.

Authors:  Hwankyu Lee; Alex H de Vries; Siewert-Jan Marrink; Richard W Pastor
Journal:  J Phys Chem B       Date:  2009-10-08       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.